Tower Research Capital LLC (Trc) Checkpoint Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.02 - $10.6 $2,113 - $21,963	-2,072 Reduced 31.84%	4,436 $5,000
Q2 2022 Aug 15, 2022	BUY	$0.97 - $1.77 $3,539 - $6,458	3,649 Added 127.63%	6,508 $7,000
Q1 2022 May 12, 2022	BUY	$1.53 - $3.25 $4,374 - $9,291	2,859 New	2,859 $5,000
Q4 2021 Feb 14, 2022	SELL	$2.68 - $4.46 $4,679 - $7,787	-1,746 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.5 - $3.53 $4,365 - $6,163	1,746 New	1,746 $6,000
Q2 2021 Aug 16, 2021	SELL	$2.36 - $3.2 $33,122 - $44,912	-14,035 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.6 - $4.16 $15,483 - $24,772	5,955 Added 73.7%	14,035 $44,000
Q4 2020 Feb 16, 2021	SELL	$2.19 - $2.96 $83,892 - $113,388	-38,307 Reduced 82.58%	8,080 $21,000
Q3 2020 Nov 16, 2020	BUY	$1.62 - $4.24 $62,209 - $162,820	38,401 Added 480.85%	46,387 $124,000
Q2 2020 Aug 13, 2020	BUY	$1.19 - $2.27 $9,503 - $18,128	7,986 New	7,986 $16,000
Q4 2019 Feb 07, 2020	SELL	$1.18 - $2.39 $2,875 - $5,824	-2,437 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$2.15 - $3.36 $2,994 - $4,680	-1,393 Reduced 36.37%	2,437 $6,000
Q2 2019 Aug 13, 2019	SELL	$2.75 - $5.0 $5,233 - $9,515	-1,903 Reduced 33.19%	3,830 $11,000
Q1 2019 May 14, 2019	SELL	$2.01 - $4.01 $23,076 - $46,038	-11,481 Reduced 66.7%	5,733 $16,000
Q4 2018 Feb 14, 2019	BUY	$1.54 - $3.35 $26,509 - $57,666	17,214 New	17,214 $31,000
Q3 2018 Nov 13, 2018	SELL	$2.46 - $4.72 $1,562 - $2,997	-635 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$2.45 - $4.39 $1,555 - $2,787	635 New	635 $2,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $351M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.